New Key Statistics Module, Z-Score and F-Score
DHA:PHARMAID Key Ratios
Market Cap BDT M | 2,044.22 |
Enterprise Value BDT M | 1,997.95 |
P/E(ttm) | 40.32 |
PE Ratio without NRI | 40.21 |
Forward PE Ratio | -- |
Price/Book | 6.04 |
Price/Sales | 5.00 |
Price/Free Cash Flow | 73.24 |
Price/Owner Earnings | 81.23 |
Payout Ratio % | 0.06 |
Revenue (TTM) BDT M | 408.00 |
EPS (TTM) BDT | 16.25 |
Beneish M-Score | -2.71 |
10-y EBITDA Growth Rate % | 8.60 |
5-y EBITDA Growth Rate % | -16.90 |
y-y EBITDA Growth Rate % | 920.40 |
EV-to-EBIT | 26.26 |
EV-to-EBITDA | 24.01 |
PEG | -- |
Shares Outstanding M | 3.12 |
Net Margin (%) | 12.40 |
Operating Margin % | 18.66 |
Pre-tax Margin (%) | 18.53 |
Quick Ratio | 2.88 |
Current Ratio | 3.36 |
ROA % (ttm) | 12.19 |
ROE % (ttm) | 16.60 |
ROIC % (ttm) | 15.85 |
Dividend Yield % | 0.15 |
Altman Z-Score | 13.78 |
DHA:PHARMAID Number of Guru Trades
DHA:PHARMAID Volume of Guru Trades
Gurus Latest Trades with DHA:PHARMAID
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:PHARMAID is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data